Clinical epidemiology and community medicine

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS6
Academic Journal
Presents an abstract of the research manuscript `Clinical predictors of deep vein thrombosis in patients with leg symptoms,' by S.R. Kahn and J.R. Leclerc from the McGill University.


Related Articles

  • Preventing thrombosis.  // Science Teacher;Jan98, Vol. 65 Issue 1, p14 

    Focuses on a study which shows that a thin polymer coating on the inside of coronary arteries may prevent acute thrombosis. Details on the study; Percentage amount of patients who undergo antioplasty which acute thrombosis occurs in; Comments from William Wagner the study's co-investigator.

  • Activated protein C resistance increases thrombosis threat. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;5/25/96, Vol. 9 Issue 5, p18 

    Reports that an inherited defect known as activated protein C resistance has recently been discovered to increase the likelihood of thrombus development. Result of coagulation protein mutation; Approach to the diagnosis of venous thrombosis.

  • Deep-vein thrombosis: The prognosis is not good.  // Modern Medicine;May96, Vol. 64 Issue 5, p44 

    Presents an abstract of the article `Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients,' by U.K. Franzeck et al., , published in `Circulation' journal in January 1996.

  • Use of enoxaparin in the treatment of catheter-related arterial thrombosis in infants with congenital heart disease.  // Cardiology in the Young;May2006 Supplement, Vol. 16 Issue S2, p27 

    The article presents the abstract "Use of enoxaparin in the treatment of catheter-related arterial thrombosis in infants with congenital heart disease," by J. Bontadelli, A. Moeller, M. Schmugge, O. Kretschmar, U. Bauersfeld, T. Schraner, V. Bernet-Buettiker, M. Albisetti.

  • Sidelining a silent killer: DVT. Capps, Lois; Rodgers, Cathy McMorris // Hill;4/24/2009, Vol. 16 Issue 46, p21 

    The article discusses deep-vein thrombosis, a life-threatening condition that affects millions of citizens in the U.S.

  • Ardeparin and danaparoid for prevention of DVT. Apgar, Barbara // American Family Physician;3/1/1998, Vol. 57 Issue 5, p1110 

    Presents a study on the prevention of deep vein thrombosis by use of ardeparin and danaparoid, which can be found in Med Lett Drugs Ther journal.

  • A Comparison of Low-Dose Heparin with Low-Molecular-Weight Heparin as Prophylaxis against Venous Thromboembolism after Major Trauma. Geerts, William H.; Jay, Richard M.; Code, Karen I.; Chen, Erluo; Szalai, John Paul; Saibil, Eric A.; Hamilton, Paul A. // New England Journal of Medicine;9/5/96, Vol. 335 Issue 10, p701 

    Background: Patients who have had major trauma are at very high risk for venous thromboembolism if they do not receive thromboprophylaxis. We compared low-dose heparin and a low-molecular-weight heparin with regard to efficacy and safety in a randomized clinical trial in patients with trauma....

  • Highlights of this Issue.  // CMAJ: Canadian Medical Association Journal;10/24/2006, Vol. 175 Issue 9, p1037 

    The article discusses various reports published within the issue, including one on the diagnosis and treatment of deep-vein thrombosis and another on obesity in an Indo-Asian population.

  • Erratum: PAK: an essential motif for forming �-turn structures and exhibiting the thrombolytic effect of P6A and its analogs. Zhao, Ming; Jia, Xin; Wang, Chao; Li, Qin; Zhou, Kexiang; Wang, Lili; Liu, Hu; Peng, Shiqi // Biochemistry & Cell Biology;Feb2008, Vol. 86 Issue 1, p80 

    A correction to the article "PAK: An Essential Motif for Forming �-turn Structures and Exhibiting the Thrombolytic Effect of P6A and its Analogs," that was published in the 2008 issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics